lberdi-Navarro
J, Ruiz-Ochoa N, De Juan-Galindez A, Uribarri-Etxebarria A. Gingival lymphatic
malformation. An atypical case report. J Clin Exp Dent. 2023;15(6):e514-7.
doi:10.4317/jced.60488
https://doi.org/10.4317/jced.60488
________
References
|
1. Elluru RG, Balakrishnan K,
Padua HM. Lymphatic malformations: diagnosis and management. Semin Pediatr
Surg. 2014;23:178-185. |
|
|
|
|
|
2. Cheng J, Liu B, Farjat AE,
Routh J. National Characteristics of Lymphatic Malformations in Children:
Inpatient Estimates and Trends in the United States, 2000 to 2009. J Pediatr Hematol
Oncol. 2018;40:221-223. |
|
|
|
|
|
3. International Society for the
Study of Vascular Anomalies ISSVA classification of vascular anomalies.
Accessed 13 February 2023 https://issva.org/classification |
|
|
|
|
|
4. Colletti G, Tombris S,
Rozell-Shannon L. Don't call me "Lymphangioma!". Oral
Maxillofac Surg. 2020;24:371-372. |
|
|
|
|
|
5. Meirelles DP, do Couto AM,
Silva LVO, Abreu LG, de Sousa SCOM, Custódio M, et al. Oral lymphatic
malformations: A multicenter study of 208 cases and literature review. Head
Neck. 2021;43:3562-3571. |
|
|
|
|
|
6. Kalwani NM, Rockson SG.
Management of lymphatic vascular malformations: A systematic review of the
literature. J Vasc Surg Venous
Lymphat Disord. 2021;9:1077-1082. |
|
|
|
|
|
7. Gomes IP, Guimarães LM, Pereira
TDSF, Braga NP, Martins MD, Gomez RS, et al. Assessment of PI3K/AKT and
MAPK/ERK pathways activation in oral lymphatic malformations. Oral Surg Oral
Med Oral Pathol Oral
Radiol. 2022;133:216-220. |
|
|
|
|
|
8. Hori Y, Ozeki M, Hirose K,
Matsuoka K, Matsui T, Kohara M, et al. Analysis of mTOR pathway expression in
lymphatic malformation and related diseases. Pathol Int. 2020;70:323-329. |
|
|
|
|
|
9. Yesil S, Tanyildiz HG, Bozkurt
C, Cakmakci E, Sahin G. Single-center experience with sirolimus therapy for
vascular malformations. Pediatr
Hematol Oncol 2016;33:219-25. |
|
|
|
|
|
10. Lackner H, Karastaneva A,
Schwinger W, Benesch M, Sovinz P, Seidel M, et al. Sirolimus for the
treatment of children with various complicated vascular anomalies. Eur J
Pediatr 2015;174:1579-84. |
|
|
|
|
|
11. Bagattoni S, Lardani L, Ligori
S, Fitzgibbon R, Carli E. Periodontology Part 2: Localised Juvenile
Spongiotic Gingival Hyperplasia: histopathological and clinical features. Eur J Paediatr
Dent. 2022;23:163-165. PMid:35722849 |
|
|
|
|
|
12. Lafuente-Ibáñez de Mendoza I,
Alberdi-Navarro J, Marichalar-Mendia X, Mosqueda-Taylor A, Aguirre-Urizar JM.
Characterization of juvenile spongiotic gingival hyperplasia as an entity of
odontogenic origin.
J Periodontol. 2019;90:1490-1495. |
|
|
|
|
|
13. Theofilou VI, Pettas E,
Georgaki M, Daskalopoulos A, Nikitakis NG. Localized juvenile spongiotic
gingival hyperplasia: Microscopic variations and proposed change to
nomenclature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:329-338. |
|
|
|
|
|
14. Tiwari P, Pandey V, Bera RN,
Sharma SP, Chauhan N. Bleomycin sclerotherapy in lymphangiomas of the head
and neck region: a prospective study. Int J Oral Maxillofac Surg. 2021;50:619-626. |
|
|
|
|
|
15. Wadhwa V, Pua BB,
Kadenhe-Chiweshe AV, Rosenblatt SD. Intralesional therapies for vascular
malformations of the head and neck. J Oral Pathol Med. 2022;51:844-848. |
|